You are here

Article info

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial

Authors

  • Marieke M ter Wee Amsterdam Rheumatology and Immunology Centre, VU University Medical Center, Amsterdam, The Netherlands Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Veerle MH Coupé Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Debby den Uyl Amsterdam Rheumatology and Immunology Centre, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Birgit S Blomjous Amsterdam Rheumatology and Immunology Centre, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Esmee Kooijmans Amsterdam Rheumatology and Immunology Centre, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Pit JSM Kerstens Westfriesgasthuis, Hoorn, The Netherlands PubMed articlesGoogle scholar articles
  • Mike T Nurmohamed Amsterdam Rheumatology and Immunology Centre, VU University Medical Center, Amsterdam, The Netherlands Amsterdam Rheumatology and Immunology Centre, Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Dirkjan van Schaardenburg Amsterdam Rheumatology and Immunology Centre, Reade, Amsterdam, The Netherlands Amsterdam Rheumatology and Immunology Centre, Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Alexandre E Voskuyl Amsterdam Rheumatology and Immunology Centre, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Maarten Boers Amsterdam Rheumatology and Immunology Centre, VU University Medical Center, Amsterdam, The Netherlands Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Willem F Lems Amsterdam Rheumatology and Immunology Centre, VU University Medical Center, Amsterdam, The Netherlands Amsterdam Rheumatology and Immunology Centre, Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Marieke M ter Wee; m.terwee{at}vumc.nl
View Full Text

Citation

ter Wee MM, Coupé VM, den Uyl D, et al
Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial
RMD Open 2017;3:e000502. doi: 10.1136/rmdopen-2017-000502

Publication history

  • Received May 23, 2017
  • Revision received August 31, 2017
  • Accepted September 11, 2017
  • First published October 25, 2017.
Online issue publication 
October 07, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/